Mrv0541 06131416342D 12 13 0 0 0 0 999 V2000 10.4701 -27.4085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.1846 -26.9960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.1846 -26.1710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4701 -25.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7556 -26.1710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7556 -26.9960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.9692 -25.9160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.9692 -27.2509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 12.4541 -26.5835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2242 -25.1315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.0311 -24.9599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.2860 -24.1754 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 2 8 1 0 0 0 0 3 2 1 0 0 0 0 3 7 1 0 0 0 0 3 4 2 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 1 6 1 0 0 0 0 7 9 2 0 0 0 0 7 10 1 0 0 0 0 8 9 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 M END > CHEBI:16765 > tryptamine > An aminoalkylindole consisting of indole having a 2-aminoethyl group at the 3-position. > 3 > CHEBI:9767; CHEBI:46157; CHEBI:15274; CHEBI:27161 > Tryptamine; 3-(2-Aminoethyl)indole; 2-(3-indolyl)ethylamine; 2-(1H-INDOL-3-YL)ETHANAMINE; 1H-indole-3-ethanamine > 2-(1H-indol-3-yl)ethanamine > C10H12N2; C10H12N2 > 160.21570 > 160.10005 > 0 > NCCc1c[nH]c2ccccc12 > InChI=1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2 > APJYDQYYACXCRM-UHFFFAOYSA-N > 125513 > 61-54-1 > 603448 > 125513 > 61-54-1 > DB08653 > C00398 > C00001434 > TRYPTAMINE > 61-54-1 > TSS > Tryptamine > 16126914; 22770225; 24345948; 24558969 $$$$